Vascular Biogenics Ltd reports results for the quarter ended in December - Earnings Summary

Notable Labs

23/03/2022 19:25

* Vascular Biogenics Ltd  VBLT.OQ  reported a quarterly
adjusted
loss of 12 cents​​ per share for the quarter ended in December.
The mean expectation of four analysts for the quarter was for a
loss of 9 cents per share.
    * Revenue fell 4.4% to $196.00 thousand from a year ago; 
analysts
expected $197.00 thousand. 
    * Vascular Biogenics Ltd's reported EPS for the quarter was
a loss
of 12 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Vascular Biogenics Ltd shares had fallen by 27.4% this
quarter.
    * The company reported a quarterly loss of $9.11 million.
    * Wall Street's median 12-month price target for Vascular
Biogenics Ltd is $5.25 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 23 at 07:25 p.m.  ​All
figures in US dollars unless otherwise stated